Xianqing Chen
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching.
Journal: Frontiers in oncology
Published: April 23, 2026
Bisphosphoglycerate mutase is involved in glucose metabolism and progression of nonalcoholic fatty liver disease based on liver organoids.
Journal: Human cell
Published: April 07, 2025
Risk factors of major bleeding detected by machine learning method in patients undergoing liver resection with controlled low central venous pressure technique.
Journal: Postgraduate medical journal
Published: June 22, 2023
Corrigendum to "TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma" [EBioMedicine 40 (2019) 446-456].
Journal: EBioMedicine
Published: May 23, 2022
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1.
Journal: Annals of translational medicine
Published: February 08, 2021
Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection.
Journal: Cancer management and research
Published: October 06, 2018
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: September 02, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026